Gajanan Bhat is a successful clinical research and development executive with a proven record in over 20 years in the development of drugs, biologics, device, radiopharmaceuticals leading to approval and launch. Gajanan Bhat is currently the Principal and founder of Celyxa, Inc, a digital health company. Prior to leaving recently, Gajanan was the Senior Vice President of Clinical Science at Spectrum Pharmaceuticals, a clinical stage oncology company for the last 10+ years responsible for a range of clinical development strategy and functions. Gajanan has worked in multiple companies over the last 20+ years with increasing responsibilities including drug, device, diagnostic product development.
